Dubai, United Arab Emirates · Arabic, English, French
You would like your face to look fresher, but you are unsure what needs to change. Your skin may feel rough, makeup may settle into fine lines, or a contour that once looked fuller may now appear hollow.
These concerns can sound similar when described as looking tired or losing your glow. They can also call for different approaches.
Skin boosters are generally chosen to improve aspects of skin quality. Volumising fillers are chosen to address specific concerns about fullness and contour. The useful starting point is identifying the change you want to see, then assessing which treatment could reasonably achieve it.
Try describing one feature without naming a procedure. You might say, “My cheeks look rough in certain light,” or, “I have lost some fullness through the middle of my face.” Each description gives the consultation a clearer direction.
It also helps to explain what you would like to preserve. Perhaps you are happy with your facial shape and want a smoother skin surface. Perhaps your skin feels comfortable, but a change in contour is bothering you.
Photographs can help communicate your concern, although lighting, expression and camera angle affect how a face appears. An examination allows your clinician to consider the skin and facial contours together before suggesting a treatment.
Skin booster is a broad term. Here, it refers to injectable treatments based on hyaluronic acid, or HA, that are used for selected skin-quality concerns. These may include roughness, hydration and the appearance of certain fine lines, depending on the product and treatment area.
The category does not describe one standard formula. Some skin-quality injectables are themselves classified as HA dermal fillers. Their intended purpose and the evidence for the specific product matter more than the label on a treatment menu.
For example, a randomised study of one HA gel found improvements in assessed cheek smoothness and fine lines compared with untreated controls. That supports a defined use. It does not establish that every skin booster produces the same result, lifts loose skin or replaces lost facial volume.
Medical reading: The 2023 randomised study of VYC-12L for cheek skin quality.
Volumising fillers are used to add fullness or alter a particular contour. Depending on the product, area and assessment, the aim might be to address cheek volume loss, enhance lip shape or soften a fold where volume contributes to its appearance.
This comparison focuses on HA fillers, although other filler materials exist. Choosing where volume belongs requires attention to facial proportions, movement and the volume already present.
A deeper fold does not automatically need to be filled directly. Similarly, marked skin laxity needs its own discussion. Adding volume cannot reproduce the removal and repositioning of excess tissue achieved with surgery. The intended change should be realistic for the anatomy being treated.
Medical reading: American Society of Plastic Surgeons guidance on filler uses and limitations.
Both may contain hyaluronic acid, but sharing an ingredient does not make two treatments interchangeable. Formulation, intended use, placement and the amount used all influence the treatment plan.
| Skin Boosters | Volumising Fillers |
|---|---|
| Main concern: Selected changes in skin quality. | Main concern: Fullness, shape or a specific contour. |
| Possible aim: Smoother-looking skin or improvement in certain fine lines. | Possible aim: Added volume or a change in contour and proportion. |
| Key assessment: Skin condition, the treatment area and the evidence for the product. | Key assessment: Anatomy, movement, existing volume and the desired change. |
| Important limit: Skin-quality improvement may leave a deeper hollow unchanged. | Important limit: More volume may leave roughness or irritation unchanged. |
Ask your clinician to connect the recommendation to your concern: what should improve, how noticeable might that improvement be, and what will the treatment leave unchanged?
Medical reading: Evidence for a skin-quality HA gel and guidance on volumising filler goals.
Rough or uncomfortable skin deserves a review of your skincare routine and any underlying irritation. Moisturiser can help the appearance of fine lines by retaining water in the skin, while sun protection remains part of ongoing care. Adding several strong products can sometimes worsen irritation.
Pigmentation, lines that appear mainly with expression and significant skin laxity also need to be distinguished from a volume concern. An injectable chosen for hydration or fullness may not address what you are actually noticing.
Be specific about symptoms. Skin that stings, flakes or develops a rash needs assessment. Treatment should be postponed in an area with active inflammation or infection until the problem has been addressed.
Medical reading: AAD advice on skincare and irritation and FDA advice on treatment suitability.
The most useful comparison starts with the change you want to see.
Sometimes an assessment identifies separate concerns about skin quality and volume. A plan may then include more than one approach, with a clear reason for each step.
For example, someone may want to discuss both a change in cheek contour and persistent surface roughness. Those observations open two questions for the consultation; they do not automatically justify two injectable treatments.
Ask which concern matters most and whether it makes sense to address that first. Staging treatment can create an opportunity to review the change before deciding on another procedure. The timing depends on the products, areas, recovery and clinical assessment. A combined plan should explain the expected benefit of each part.
A useful consultation covers your goals, skin condition, facial anatomy and treatment history. Bring details of previous injections if you have them, including the product, date and area.
Tell your clinician about:
These details can change suitability and timing. Do not stop a prescribed medicine yourself to prepare for treatment. Ask how the proposed product fits your concern, what alternatives are reasonable and what the full plan will cost.
Medical reading: AAD guidance on preparing for filler treatment and patient information for a skin-quality HA injectable.
The method, comfort measures and appointment length depend on the product and area. Both approaches involve injections, and either can cause tenderness, redness, swelling or bruising. Small visible bumps can occur with some skin-quality treatments.
HA filler may create an early visible change in fullness, but swelling can affect that initial appearance. Skin-quality results also need an appropriate review interval. Ask when you should judge the outcome and when to contact the clinic about something unexpected.
Follow the aftercare instructions for your treatment, including advice about exercise, heat, makeup and other procedures. Allow time before an important event. A treatment described as subtle can still leave visible signs while it settles.
Medical reading: AAD information on results and recovery and skin-quality injectable patient information.
There is no single duration that applies to every skin booster or every volumising filler. The product, treatment area, protocol and outcome being measured all matter.
In the 2023 cheek study, improvements in assessed smoothness and fine lines were maintained through six months of follow-up. This was evidence for one product and treatment protocol, with manufacturer involvement. It was not a comparison with all other injectables or a promise that every patient would see the same change.
Ask about the initial plan, any proposed touch-up and the likely review schedule. Maintenance should follow an assessment of what remains and what still concerns you. A date on the calendar alone does not explain why more treatment is needed.
Medical reading: The VYC-12L study and six-month follow-up and AAD information on filler duration.
Both are medical procedures. Alongside common injection reactions, possible complications include infection, persistent lumps and delayed inflammation. Rarely, an injection can block a blood vessel and cause serious tissue injury or visual damage, including loss of vision.
A hydration-focused purpose or a small amount of product does not remove injection risks. Your clinician should explain the risks relevant to the proposed product and area, and how complications would be recognised and managed.
Unusual pain, white, grey or blue skin, or any change in vision during or after an injection requires immediate medical attention. Contact the treating clinician immediately; for visual changes, seek emergency care without delay.
Medical reading: FDA information on filler complications and warning signs and safety information for a skin-quality injectable.
Dr. Nivine’s assessment considers whether the main concern relates to skin quality, volume loss, laxity or another issue. Facial proportions, movement, previous injectable treatments and your preferred result help guide the discussion.
You can arrive with a concern rather than a product request. Explain what has changed, what bothers you and how much change would feel comfortable. If you have previous treatment records, bring them along.
A useful plan makes the reasoning clear: the concern being treated, the change being proposed, the limitations and the point at which the result will be reviewed. That gives you a more meaningful basis for deciding whether to proceed.
General patient education. Suitability, product selection and treatment timing require an individual medical assessment.
You notice more hair in the shower, a fuller hairbrush or a ponytail that feels smaller. Looking back, the change seems to have followed a period of weight loss.
It is understandable to wonder whether you are missing a nutrient, reacting to a medicine or developing a longer-term hair problem. The timing offers a useful clue, but it needs to be considered alongside the pattern of hair loss and your general health.
The first checks are when the shedding began, what the scalp and hair look like, and how your food intake changed. Those findings help determine whether blood tests, nutritional support or a specific hair treatment would be useful.
Significant weight loss or a marked change in diet can trigger telogen effluvium, a form of increased shedding. More hairs than usual move into the resting stage of the hair cycle and are shed later. The follicles generally remain capable of producing new hair.
The delay matters. Shedding commonly becomes noticeable around two to four months after a trigger, sometimes when your weight or eating routine already feels more settled. A change you made last week may therefore be less relevant than what happened several months earlier.
Write down when weight loss began, when you noticed the shedding and any recent illness, fever, surgery, childbirth, major stress or medication change. Several events can overlap. A useful history follows the whole sequence.
Medical reading: DermNet on telogen effluvium and its timing.
Telogen effluvium usually causes shedding across the scalp. You may notice reduced overall volume rather than a single bare patch.
A widening part, a changing hairline, distinct patches or many broken strands can point towards other causes. Pattern hair loss may also become more noticeable during a shedding episode, so two conditions can be present together.
A clinician examines the scalp, hair density and hair shafts, and may use magnification or a gentle hair pull test. Redness, scale, tenderness and changes around the follicles also matter. This examination helps distinguish hair shedding from breakage, inflammation and conditions that need a different approach.
Medical reading: British Association of Dermatologists on shedding patterns and AAD guidance on diagnosing hair loss.
A nutritional review looks at what you are actually able to eat. Appetite changes, smaller portions, skipped meals, nausea or avoiding whole food groups can make it harder to meet your needs.
Too little overall energy or insufficient protein can contribute to hair loss. A meal pattern that looks balanced on paper may still provide too little if the portions have become very small.
Bring a simple record of a few typical days, including meals, snacks, drinks and supplements. A clinician or dietitian can assess the amount and variety of food, identify gaps and agree on practical adjustments. Protein needs should be considered individually alongside your health and weight-management plan.
The aim is to support adequate nutrition while reviewing the pace and method of weight loss. Further restriction is unlikely to answer the question of why your hair is shedding.
Medical reading: AAD guidance on nutrition and hair health.
Blood tests can help when the history or examination suggests an underlying problem. The selection depends on factors such as dietary restriction, heavy periods, symptoms, previous results and any history of bariatric surgery.
| Possible test | What it may clarify |
|---|---|
| Complete blood count | Whether anemia or another blood-count abnormality needs attention. |
| Ferritin and, when needed, other iron studies | Whether iron stores may be low and how the result fits with the rest of the assessment. |
| Thyroid function | Whether a thyroid problem may be contributing, when the clinical picture supports checking. |
| Selected nutrient tests | For example, vitamin B12, folate or zinc when dietary history, symptoms or a surgical follow-up plan makes them relevant. |
A normal hemoglobin result does not always mean iron stores are adequate. Ferritin also needs context. Inflammation can raise it, so a result should be interpreted alongside symptoms, the blood count and other iron tests when appropriate. Finding a deficiency also means considering why it developed.
Normal blood results do not exclude every cause of hair loss. The scalp examination remains important, and a broad supplement plan should not be based on a hair complaint alone.
Medical reading: British Association of Dermatologists on testing, MedlinePlus on iron tests and BOMSS nutritional monitoring guidance.
If the shedding follows bariatric surgery, tell your clinician which procedure you had and when. Surgery, weight change, reduced intake and procedure-specific effects on nutrient absorption can all be relevant.
Your bariatric team or dietitian should review food tolerance, protein intake, prescribed supplements and follow-up blood tests. Continue the supplement plan prescribed after your operation unless your treating team changes it. Preventive supplementation after bariatric surgery has a different purpose from buying a general hair supplement.
Repeated vomiting, difficulty swallowing or an inability to eat and drink adequately needs prompt contact with your medical or surgical team. These symptoms should be assessed before waiting to see whether the hair improves.
Medical reading: BOMSS guidance on review after bariatric surgery and BOMSS nutritional guidance.
Bring the names and doses of prescribed medicines, over-the-counter products and supplements. Include when each was started or changed. If you take a weight-loss medicine, describe any appetite changes or difficulty maintaining food intake.
Your prescriber can consider the medicine, the weight change and other possible triggers together. Speak with them before changing or stopping a prescribed treatment.
Biotin deserves a specific mention. It is common in products marketed for hair, but evidence for routine supplementation to improve hair is limited. It can also interfere with some laboratory tests, including certain thyroid tests. Tell the clinician and laboratory what you take, and follow their instructions before testing.
Medical reading: AAD advice on medicines and hair loss and NIH information on biotin.
The most useful first step is understanding the shedding pattern and what changed before it began.
Keep washing gently with a suitable shampoo and use conditioner to reduce tangling and breakage. Avoid vigorous brushing, tight hairstyles, frequent high heat and harsh chemical treatments while the hair feels fragile.
Adding several hair supplements at once can make it difficult to know what you are taking. Excess amounts of some nutrients can be harmful and may themselves worsen hair loss. Bring the labels to your appointment before adding another product.
Take occasional photographs of your parting and hairline in similar lighting. These can make follow-up discussions more useful than repeatedly checking the hairbrush throughout the day.
Medical reading: AAD guidance on gentle hair care and supplements.
The diagnosis determines the next step. With a temporary shedding episode, correcting an ongoing trigger and allowing the hair cycle to recover may be enough. A confirmed deficiency, thyroid problem or scalp condition needs its own management.
If pattern hair loss is also present, the discussion may include a treatment such as topical minoxidil after assessing suitability. That is a different decision from treating a short-lived shedding episode.
Before starting a procedure, ask what it is intended to address, what evidence supports it for your diagnosis and how progress will be reviewed. Any treatment should form part of a plan that also addresses an ongoing medical or nutritional cause.
Medical reading: AAD guidance on treatment selection and DermNet on managing telogen effluvium.
Hair responds slowly. Even after a trigger is addressed, hairs that have already entered the resting stage may continue to shed for a while.
In an acute episode, the shedding phase often lasts several months. A return of fullness takes longer, because new hairs need time to grow. Many people improve over the following six to nine months, while recovery of their previous length and volume can take longer.
Ongoing triggers or another hair condition can change that course. Arrange follow-up if shedding persists beyond six months, density continues to decline or the expected improvement is not happening. You can seek help earlier whenever the change concerns you.
Medical reading: AAD on recovery after shedding and British Association of Dermatologists on persistent shedding.
Arrange a review for distinct bald patches, a rapidly changing hairline, eyebrow loss or persistent scalp redness, scaling, pain or sores. These findings need an explanation beyond the timing of your weight loss.
Discuss accompanying fatigue, heavy periods, digestive symptoms or difficulty eating. If the weight loss was unintentional, or continues without changes to diet or activity, seek a medical assessment of the weight loss itself.
You do not need to wait until thinning is severe. An earlier examination can establish what is happening and give you a practical plan for monitoring it.
Medical reading: AAD on hair-loss signs and symptoms and NHS guidance on unintentional weight loss.
Bring your timeline, recent blood results, medication and supplement list, and a few photographs showing the change. If you have a weight-management or bariatric care team, include the details of their current plan.
With Dr. Nivine Cheaito, you can discuss the shedding pattern, scalp findings, nutritional factors and your treatment history. The aim is to understand what needs attention first and agree on suitable care, further medical review where needed and a sensible follow-up plan.
Pigmentation can become noticeable again because the factors that produced it are still active. Treatment may have lightened an existing patch while sunlight, hormonal influences or inflammation continue to encourage pigment production. In other cases, new marks are forming as older ones fade, or some of the original discoloration never fully cleared.
That can feel frustrating, particularly when your skin initially looked more even. The useful next step is to establish what has changed. Understanding the type of pigmentation, its triggers and your previous response helps explain why the color returned and what to do next.
Melasma usually appears as broader, uneven brown patches, often across both cheeks, the forehead or above the upper lip. It can improve with treatment and become more noticeable again because it is often a relapsing condition.
Post-inflammatory hyperpigmentation is the dark mark left after inflammation or injury, such as a breakout, eczema or irritation. It can affect any skin tone, but the marks are often more pronounced and persistent in darker skin.
Sun spots, also called solar lentigines, are usually more distinct spots on areas exposed to sunlight over time. Their behavior and treatment options differ from those of melasma.
These concerns can coexist. The location or shade alone cannot reliably establish which one you have, so an examination should come before choosing another treatment.
Clinical background: DermNet’s guides to melasma, post-inflammatory hyperpigmentation and sun spots.
What looks like recurrence can represent different changes. Melasma may darken again in a familiar pattern. An acne mark may still be fading when a nearby breakout leaves another spot. A treated area may also retain some pigmentation that becomes easier to notice under different lighting.
Think about the sequence. Did the patch disappear completely? Did the color return in the same area? Was there a breakout, a new product or a procedure between the improvement and the change?
These details help your clinician judge whether the priority is managing a relapsing condition, allowing more time for fading or addressing a new trigger. Recurrence by itself does not establish that the previous treatment failed.
Ultraviolet light can encourage pigment production, darken existing marks and contribute to further sun spots. Exposure continues between appointments, including during ordinary outdoor activities. A treatment course does not remove the need for ongoing protection.
For melasma, visible light from sunlight also matters. A tinted sunscreen containing iron oxides can add protection against this part of sunlight. The SPF number alone does not tell you how well a product protects against visible light.
A clinical trial found greater melasma improvement with a sunscreen providing UV and visible-light protection than with a UV-only comparator. Both groups also used a prescribed pigment cream. This supports visible-light protection as part of a wider plan; it does not establish sunscreen as a cure.
Further reading: AAD guidance on melasma and light protection and the randomized trial of UV and visible-light protection.
Pregnancy and some hormonal medicines, including certain contraceptives, can contribute to melasma. A patch may therefore remain active even after the visible color has improved with treatment. Several influences can be present at the same time.
Tell your clinician when the pigmentation began and whether it coincided with pregnancy or a medication change. Also mention pregnancy plans and breastfeeding, because these affect the suitability of some pigment treatments.
This history provides context; a dark patch alone does not prove that you have a hormone disorder. If a medicine may be relevant, discuss it with the clinician who prescribed it before making any change.
Clinical background: AAD’s explanation of melasma causes and British Association of Dermatologists patient information.
When acne, eczema or irritation remains active, new pigmentation can develop while older marks are fading. The skin may seem to be making little progress even though individual spots have become lighter.
This is why treatment needs to address the condition creating the marks. Repeatedly picking a blemish, scrubbing irritated skin or layering products that cause burning can add further inflammation. A pigment serum has a limited role if the source of irritation continues.
Bring your full routine to the appointment, including products used only occasionally. The timing of a new exfoliating product, scrub or home peel may help explain a change. If a product causes persistent burning or irritation, stop using it and ask for advice before adding another active ingredient.
Patient information: AAD guidance on treating the causes of dark marks.
Understanding what keeps triggering the pigment helps make the next treatment decision clearer.
Selected chemical peels, lasers and light treatments can improve particular pigment concerns. Their usefulness depends on the diagnosis, the skin being treated and the previous response. A method suitable for a defined sun spot may have a different role in melasma.
Procedures can also cause inflammation and lead to new pigmentation. This risk deserves particular attention in skin that has previously developed dark marks after irritation or injury. Melasma may worsen after an unsuitable procedure, even when the original aim was to lighten it.
If pigmentation returns after treatment, review the timeline and the skin’s recovery before repeating the procedure. Ask what the proposed treatment is intended to change, what risks apply to your skin and how ongoing care will support the result.
Clinical background: DermNet’s guidance on procedural pigmentation and BAD’s explanation of melasma treatment risks.
For a condition such as melasma, lighter patches do not necessarily mean the tendency to produce excess pigment has ended. A maintenance plan can help protect the improvement and establish what to do if the color begins to return.
The initial treatment and the ongoing routine may differ. Your clinician may adjust a prescription, simplify the routine or continue selected products alongside sun protection. Prescription pigment creams need clear instructions about duration and review; they should not be continued indefinitely without supervision.
Before finishing a course, ask which products to continue, which to stop and when to return. Maintenance should fit your diagnosis and response. It does not automatically require a continuing series of procedures.
Patient information: AAD guidance on individualized melasma treatment and BAD information on recurrence and supervised care.
Pigmentation often improves gradually over months. The type of pigmentation, how deeply pigment sits in the skin and whether new triggers remain active all affect the course. A dark mark after inflammation can take considerably longer to fade than the blemish that caused it.
Ask what progress is realistic for your diagnosis and when the response should be reviewed. Compare photographs taken in similar lighting, without filters or makeup, so you can see changes more clearly.
Slow improvement deserves a planned review, especially if there is no meaningful change by the agreed point. New patches, persistent irritation or unexpected worsening should be discussed sooner. A fixed number of sessions cannot guarantee clearance for every type of pigmentation.
Further reading: AAD guidance on how long dark marks can take to fade and melasma treatment expectations.
A useful assessment connects the appearance of your skin with its history. Your clinician should examine the pattern and discuss when it developed, how it has changed and what happened after previous treatments.
Bring information that can make the discussion more specific:
A new or changing individual spot, particularly one that enlarges, develops irregular colors or bleeds, should be medically examined before cosmetic treatment. An established pigment diagnosis should not be assumed to explain every new mark.
Patient information: Mayo Clinic guidance on spots that need assessment.
Start with a broad-spectrum, water-resistant sunscreen with SPF 30 or higher. Apply it generously before going outside and reapply at least every two hours outdoors, and after swimming or sweating, following the product instructions. Use shade and a wide-brimmed hat as additional protection.
If you have melasma, discuss a tinted formula containing iron oxides. Choose a texture and shade you can comfortably use in the recommended amount.
Keep cleansing gentle and use a suitable moisturizer. Follow the agreed schedule for pigment products, and check before combining several exfoliating or prescription treatments. A routine that repeatedly leaves your skin sore needs adjustment.
Your everyday plan should be practical enough to continue between appointments and clear enough that you know when to seek a review.
Patient information: AAD’s daily care recommendations and Mayo Clinic advice on limiting new sun spots.
When pigmentation keeps coming back, the next appointment should help you understand the pattern. You should leave knowing the likely diagnosis, the purpose of any proposed treatment and how the response will be assessed.
The plan may involve addressing inflammation, changing a skin care routine, using a prescribed treatment or considering an appropriate procedure. Its value comes from how well those decisions fit your skin and previous experience.
For an individual pigmentation consultation in Dubai, book an appointment with Dr. Nivine Cheaito. Bring your treatment history and the questions you still have about recurrence, so your next step can include both improvement and ongoing care.
You have slept well, feel alert and are ready for the day. Then someone asks if you are tired.
It can be frustrating when your face seems to tell a different story from how you feel. Perhaps concealer helps with the color beneath your eyes, but a shadow remains. Or the puffiness you notice in the morning never seems to disappear completely.
A tired-looking face can reflect pigmentation, the shape of the eye area, puffiness or changes in skin texture. These features can overlap, and better sleep may only influence part of the picture. Understanding what you are actually seeing makes it easier to decide what might help.
A good night’s sleep supports your wellbeing, but it does not change every feature that makes a face appear tired. You may naturally have deeper under-eye grooves, more visible color beneath thin skin or a family tendency to dark circles.
Being short of sleep can make existing circles more noticeable. Getting adequate rest, however, does not necessarily remove a feature that has been present for years. If the appearance persists when you feel rested, it is reasonable to look beyond your bedtime routine.
Medical reading: Mayo Clinic on dark circles.
The phrase “dark circles” describes an appearance. It does not identify which part of the skin or surrounding anatomy is responsible.
Pigment in the skin. Increased melanin can create a brown or darker appearance. Genetics, sun exposure and pigmentation following irritation may contribute.
Structures showing through thin skin. The lower eyelid skin is delicate. Underlying blood vessels can contribute to a darker or bluish appearance, particularly when the skin is thin.
A shadow over the skin. A hollow, a prominent bag or the transition between the eyelid and cheek can cast a shadow. That darkness may change when the direction of the light changes.
Several causes can be present together. Color alone, especially in a photograph, is not enough to identify the cause or choose a treatment.
Medical reading: DermNet on the causes of under-eye darkness.
The tear trough is the groove that begins near the inner corner of the eye and follows the lower eyelid towards the cheek. Its depth varies between people. In some faces, the contour is noticeable from a young age; in others, it becomes more apparent as the surrounding tissues change.
A more pronounced transition can create a shadow even when the skin itself has little extra pigment. This helps explain why a brightening cream may improve color without changing the dark line beneath it.
The cheek and lower eyelid should be considered together. The question is how their contours relate to each other and whether that relationship is contributing to the concern you want to address.
Medical reading: EyeWiki on tear trough anatomy and assessment.
Temporary fluid accumulation can make the eye area appear fuller, particularly on waking. Allergies and a salty meal may contribute. A pattern that changes during the day is useful information to bring to a consultation.
Persistent bags may also involve changes in the tissues supporting the eyelids, with fat becoming more prominent and skin becoming looser. Sleeping longer will not necessarily change those structures.
A bag can sit immediately above a hollow. The raised area catches the light while the groove beneath it appears darker, making the contrast more obvious. This combination needs a different discussion from a simple change in skin color.
Medical reading: Mayo Clinic on under-eye bags and swelling.
If your eyes itch, your eyelids flake or the skin stings when you apply products, the concern deserves more than another eye cream. Allergy, eczema or a reaction to a product may be involved.
Repeated rubbing can contribute to irritation and pigmentation. A stronger brightening product may add to the problem if the skin is already inflamed. Notice whether symptoms began after a change in cosmetics, cleanser, hair dye or another product, and share that history with your clinician.
Persistent irritation should be assessed so that care can address its cause. Once the skin is comfortable, it becomes easier to judge which appearance concerns remain.
Medical reading: NHS guidance on eyelid problems and Mayo Clinic on irritation and dark circles.
A tired appearance is not always concentrated beneath the eyes. Brow position and excess upper eyelid skin can make the area look heavier. A true drooping eyelid is a separate clinical finding and needs appropriate assessment, particularly if it affects vision.
Dryness can also make superficial fine lines look more noticeable. Moisturizer may soften their appearance, although it cannot reshape an eyelid or replace tissue volume.
This is why it helps to point out the feature that bothers you. “My eyes look heavy” may refer to the upper lids, while “I look drawn” may refer to a shadow beneath them. Those descriptions can lead to different findings.
Medical reading: ASOPRS on eyelid skin and brow position, Moorfields on drooping eyelids and AAD guidance on moisturizer and fine lines.
Daily care can support the skin and reduce avoidable irritation. Keep the routine simple enough to follow consistently.
Medical reading: AAD guidance on gentle skin care and Mayo Clinic on practical care for puffiness.
A useful assessment starts with what you see: color, contour, puffiness or texture.
Describe when you first noticed the change, whether it affects one or both sides and whether it fluctuates. Mention allergies, eye symptoms, medicines, previous facial surgery and any filler, including treatment performed years ago.
Older photographs can help show whether a contour is longstanding. If you take new photographs, use similar lighting, camera distance and facial position so that differences are easier to interpret.
The examination should consider pigmentation, skin quality, hollows, swelling, fat prominence and the relationship between the eyelids and cheeks. Your own priority matters too. Ask which feature a proposed treatment would address, what would probably remain and how its risks apply to you.
Medical reading: EyeWiki on assessment of the tear trough and Mayo Clinic on preparing for an appointment.
When dryness or irritation is the main issue, skin care or treatment of an underlying skin condition may be the appropriate starting point. Pigmentation may call for a tailored topical plan. Selected peels or laser treatments require careful assessment of the eyelid area and skin tone, because irritation and pigment changes can occur.
For a suitable patient with a defined hollow, hyaluronic acid filler may soften the contour and the shadow it creates. It does not remove melanin or a protruding fat pad. A tendency to swelling needs particular attention, and adding volume can make some puffy under-eyes look fuller.
Filler also carries risks, including bruising, swelling, lumps and infection. Rare injection into a blood vessel can damage skin or threaten vision. Product choice, anatomy, medical history and the clinician’s experience all belong in the consultation.
If prominent fat bags or excess eyelid skin are the main concern, a specialist eyelid opinion may be useful. A treatment should have a clear purpose; several different concerns may need a staged approach.
Medical reading: ASPS on treatment selection and filler limitations, Mayo Clinic on treatment considerations and FDA information on filler risks.
Arrange a medical assessment for a new or worsening change beneath one eye, or swelling and irritation that persist. Seek urgent care for a sudden drooping eyelid, changes in vision, significant eye pain or a red, hot, painful swollen eyelid.
Feeling tired is a separate concern from looking tired. If unexplained fatigue lasts for several weeks, affects daily life or comes with other symptoms, discuss it with a medical clinician. Sleep quality, medicines and health conditions may need review. Tests, if needed, should follow that assessment.
Medical reading: NHS guidance on eyelid symptoms and NHS guidance on persistent fatigue.
If your face continues to look tired when you feel well rested, a consultation can help you understand the features involved. You do not need to arrive with a treatment already chosen.
With Dr. Nivine Cheaito, you can discuss under-eye color, puffiness, hollows and changes in skin texture, along with the improvement you would like to see. The first step is a clear assessment, followed by a conversation about suitable care and realistic expectations.
Your usual moisturizer may no longer keep your skin comfortable. Makeup catches on dry patches, your cheeks feel tight after cleansing, and spots have returned around your chin. When several changes appear close together, it can feel as though your skin has become unfamiliar.
Perimenopause can be part of the explanation. Changing hormones may affect moisture retention, sensitivity and the way skin looks and feels. Your routine, sun exposure, medicines and existing skin conditions also matter. A useful assessment brings these details together, so you can understand what your skin needs now.
Perimenopause is the transition leading up to menopause. During this time, ovarian hormone levels fluctuate and menstrual cycles often become less predictable. Symptoms can develop while you are still having periods, and the transition can last several years.
Natural menopause is identified after 12 consecutive months without a period when this is not explained by hormonal contraception or another cause. It commonly occurs between 45 and 55, although the timing varies and some people experience it earlier.
Your 40th birthday does not mark a fixed starting point for hormonal skin changes. The wider pattern, including your periods and other symptoms, is more informative than age alone. Dryness or acne by itself cannot confirm perimenopause.
Clinical background: NHS definitions of menopause and perimenopause and UCLH’s explanation of the transition.
Hormone levels can rise and fall during perimenopause, so symptoms may be variable. At the same time, the effects of normal aging and accumulated sun exposure continue. Several influences can become noticeable together.
You may first notice the difference through an everyday experience: a familiar cleanser leaves tightness, makeup sits differently, or your usual acne routine becomes uncomfortable. Those observations are useful, even if the underlying change has been developing gradually.
Consider what else changed around the same time. A new exfoliant, a prescription, more time outdoors or a flare of an existing skin condition can affect the picture. Describing the sequence helps your clinician identify which factors deserve attention.
Further reading: UCLH on fluctuating hormones and DermNet on the different influences on skin aging.
Estrogen helps support skin hydration, including components involved in retaining moisture. As hormonal support changes through the menopause transition, some women notice drier skin. This can show up as tightness, fine flaking, itching or a need to moisturize more often.
The skin’s outer layer helps keep moisture in and irritants out. Its current condition matters when choosing products. A routine that once felt comfortable may need adjustment if cleansing or active ingredients now leave the skin sore.
Dryness also has other causes. Frequent washing, hot water, dry air and skin conditions such as eczema can contribute. If the discomfort persists despite gentle care, an examination can help establish what needs treatment.
Clinical background: DermNet’s guide to menopause and the skin and AAD guidance on persistent dryness.
Skin that has become drier or more easily irritated may tolerate a familiar product differently. Fragrance, repeated exfoliation and strong acne products can become harder to manage. Persistent burning is a reason to review the routine.
Flushing also needs context. A hot flush may temporarily make the face, neck or chest feel hot. Ongoing facial redness, visible vessels, bumps or burning may involve a skin condition such as rosacea. Eczema or contact irritation can also cause symptoms that deserve their own assessment.
Describe how long each episode lasts and whether a particular product or activity precedes it. These details help distinguish a passing flush from a persistent skin problem.
Patient information: AAD guidance on sensitivity and existing skin conditions and NHS information about hot flushes.
Acne can persist into adulthood or begin after years of relatively clear skin. Hormonal fluctuations may contribute during perimenopause, but stress, skin and hair products, medicines and genetic susceptibility can also play a role.
Breakouts can coexist with dry or sensitive areas. Removing as much oil as possible may leave the skin more irritated without controlling the acne. The treatment needs to consider both the blemishes and the condition of the surrounding skin.
Share any pattern around your periods and the names of products or medicines you recently started. If you suspect a medicine is contributing, discuss it with the prescriber before changing it. Persistent, painful or scarring breakouts are a good reason to seek treatment rather than repeatedly switching products.
Clinical background: AAD’s explanation of adult acne.
Estrogen supports collagen and other aspects of skin structure. Across the menopause transition and afterward, some women notice less firmness, thinner-looking skin or more visible lines. The timing and extent vary, alongside the effects of age and sun exposure.
Surface dryness can also make fine lines and texture more noticeable. Moisturizing may improve the appearance of that dryness, while deeper folds, facial volume changes and skin laxity need a different assessment.
Be specific about what has changed. Is it the way makeup settles, a rough patch, an expression line or a change in facial contour? Each description points to a different treatment discussion. A general concern about aging becomes easier to address when the area and goal are clear.
Further reading: AAD on changes in skin firmness and DermNet on skin aging.
Your routine should fit the skin you have now.
Begin with the basics your skin can tolerate. A manageable routine makes it easier to judge whether a product helps and whether something is causing irritation.
A retinoid may be useful for selected concerns such as acne, fine lines or uneven tone, but the formula and schedule must suit your skin. Retinoids should not be used during pregnancy. Pregnancy remains possible during perimenopause, so mention pregnancy plans and breastfeeding when discussing treatment.
Patient information: AAD guidance on dry skin care and retinoid suitability, with NHS information on pregnancy during perimenopause.
Arrange a review if dryness, itching, a rash or breakouts persist, or if a new change is difficult to explain. Substantial hair shedding, rapid changes in facial hair or a changing individual skin lesion also deserve assessment.
For the wider perimenopause discussion, note changes in your periods, hot flushes, night sweats, sleep and other symptoms. Bring your current medicines, contraception details and skin care products. A short symptom record can help connect changes that seem unrelated.
Hormone blood tests are not automatically needed. In otherwise healthy people aged 45 or older with a typical pattern, assessment is usually based on symptoms and menstrual history. If you are younger or the cause is less clear, targeted tests may be useful, including investigation of other possible causes.
The skin examination and the broader medical history answer different parts of the same concern.
Patient information: NHS symptom guidance and UCLH’s explanation of diagnosis and testing.
Menopausal hormone therapy, often called HRT, may be considered for appropriate menopausal symptoms after an individual medical assessment. The decision takes account of your symptoms, health history, preferences and the benefits and risks of the proposed treatment.
Hormone therapy may improve some skin changes, but it is not currently advised solely to improve skin appearance. A possible skin benefit belongs within the wider treatment discussion. It does not establish that everyone with dryness or fine lines needs hormones.
If night sweats, sleep disruption or other symptoms are affecting you, speak with a clinician experienced in menopause care. Continue to have persistent skin conditions assessed in their own right, including when you already use hormone therapy.
Clinical background: The Menopause Society’s hormone therapy guidance and a clinical education article on menopause and skin.
Once the concern has been assessed, treatment can be planned around a specific aim. Improving surface texture, treating acne, softening an expression line and addressing a change in facial volume involve different decisions.
Some concerns may respond to a suitable topical treatment. Selected procedures may be discussed for a defined issue, such as pigment, texture or facial structure. Suitability depends on your skin, medical history and preferences, with the expected benefit, recovery and risks explained beforehand.
If your skin is currently inflamed or unusually reactive, the first step may be to diagnose and settle that problem. Ask how the proposed treatment fits with your routine and whether the timing needs adjustment.
A useful plan gives each treatment a clear purpose and a way to review the response. Aesthetic procedures do not correct the underlying hormonal transition.
Clinical background: AAD on selecting topical treatment and individualized skin care and procedural options during menopause.
The most useful starting point is the change that bothers you: discomfort, new breakouts, a persistent patch or a difference in texture. Explaining that concern clearly helps create a plan you can understand and continue.
Your plan should set out the role of daily care, any treatment being considered and when to review progress. If the history suggests a wider perimenopause concern, that can be discussed with an appropriate clinician alongside care for your skin.
For an individual skin consultation in Dubai, book an appointment with Dr. Nivine Cheaito. Bring your current routine, previous treatment details and questions, so the next step can reflect your skin’s condition and the change you would like to address.
Old lip filler does not automatically need to be dissolved before another treatment. The decision depends on what is already present, how your lips look and feel, and the change you want to make. If the existing result is settled and well positioned, your doctor may consider a carefully planned top-up. If there is excess fullness, an unwanted contour or an unresolved reaction, the next step may be correction or further assessment.
Understanding the difference helps you approach your next appointment with a clearer goal. You may want to restore a little volume, refine the outline or return to a softer appearance. Each of these starts with a review of your previous treatment and the lips you have today.
Most lip fillers contain hyaluronic acid (HA), a substance used in gel formulations to add volume and shape. These fillers gradually break down, but their duration varies. The product used, the area treated and your individual response all influence how the result changes over time.
The date of your last appointment therefore gives only part of the picture. A softer appearance does not confirm that every trace of filler has disappeared. Previous treatment may still be contributing to the fullness, outline or projection of your lips.
A repeat appointment should account for that existing result. For example, someone who likes their lip shape and notices a gradual reduction in fullness has a different concern from someone whose upper lip already feels too prominent. The same interval between appointments can lead to different recommendations.
A top-up may be discussed when the lips have settled, the existing result remains balanced and there is a clear reason for further treatment. Your doctor should assess the current volume, symmetry and movement, along with any symptoms and the outcome you would like to achieve.
That conversation might focus on restoring a small amount of fullness or refining a particular area. It may also establish that your lips already have enough volume for the result you want. The treatment plan should follow the assessment, including the possibility of reviewing again later.
Repeat lip filler treatment has been studied as a maintenance approach. This supports discussing a top-up individually, while your current result and medical assessment determine whether another injection is appropriate.
Clinical background: prospective research on repeat lip filler treatment.
Dissolving may be considered when existing hyaluronic acid filler is contributing to a concern that additional volume would not address. The reason for correction should be clear before treatment begins.
Concerns that may lead to this discussion include:
These concerns need to be interpreted in context. Swelling after a recent treatment can temporarily change the outline, while natural lip asymmetry may have been present beforehand. A photograph or a blurred border alone cannot establish that filler has migrated.
Persistent or recurring swelling, tenderness, redness or a new lump calls for a medical assessment. Inflammation and infection are among the possible explanations, and the treatment depends on the cause. An infection needs appropriate management before an elective refill is considered.
Clinical background: expert consensus on delayed reactions to hyaluronic acid fillers.
Your next lip treatment starts with understanding the result you already have.
Hyaluronidase is an enzyme that breaks down hyaluronic acid. A qualified clinician can inject it to reduce HA filler where correction is needed. The response depends on the filler, its amount and location, and the reason for treatment.
Different products can respond differently, and some corrections require more than one session. Your doctor will review the response before deciding whether further dissolving is appropriate.
This approach applies to hyaluronic acid filler. Materials such as silicone, calcium hydroxylapatite and poly-L-lactic acid do not dissolve in the same way with hyaluronidase. Knowing which product was used is an important part of planning correction.
Clinical background: review of hyaluronidase for filler complications.
In some cases, a clinician may aim to reduce filler in a particular area while retaining some of the existing enhancement. This may be discussed when the concern is localized and the rest of the result remains suitable.
Selective correction has limits. Hyaluronidase can spread through the surrounding tissue and affect nearby HA filler, so the amount removed cannot be controlled with absolute precision. A plan to soften one area should include that possibility.
More extensive dissolving may be considered when several areas need correction or the overall volume is no longer wanted. The aim, expected changes and need for reassessment should be agreed in advance.
Further reading: ASPS guidance on the possibilities and limits of dissolving filler.
A useful assessment considers the lips from the front and side, at rest and during movement. The outline, projection and relationship between the upper and lower lip help define what you are noticing. Your doctor will also examine any areas of firmness, swelling or tenderness.
It helps to explain the change in your own words. You might want a softer upper border, less projection or a more even appearance when you smile. These details give the consultation a more useful starting point than a request for a particular syringe size.
Bring as much of your treatment history as you can, including:
Tell your doctor about any previous reaction to hyaluronidase and any significant bee or wasp sting allergy. If the original product is unknown or the examination leaves uncertainty, further assessment may be needed before an injection is planned.
Dissolving is a treatment with its own recovery period. Temporary tenderness, swelling and bruising can occur, and the lips may change in appearance as they settle. The result immediately after the appointment should not determine the amount of new filler to add.
Your lips may look noticeably smaller as the added volume reduces. Hyaluronidase can also affect naturally occurring hyaluronic acid, which the body replenishes. Recovery and the final appearance vary, so follow-up matters if you have concerns about shape, texture or persistent symptoms.
Your clinician should explain aftercare, the expected course of recovery and how to contact the practice. Follow those instructions and avoid trying to manipulate or dissolve filler yourself.
Patient information: Cleveland Clinic’s guide to dissolving lip filler.
For elective correction, published expert guidance recommends waiting at least two weeks before reinjecting filler, with a longer interval when significant swelling remains. Your clinician may recommend additional time depending on the reason for dissolving and how the tissues recover.
This allows the next decision to be based on settled lips. At review, your doctor can assess the remaining volume, the contour and whether the original concern has improved. If further dissolving or treatment of an underlying problem is needed, the plan changes accordingly.
A same-day dissolve-and-refill appointment does not allow for that reassessment. Plan for separate stages and discuss upcoming travel, events or photography before committing to a treatment date.
Clinical background: CMAC guidance on hyaluronidase and elective retreatment.
Contact your clinician promptly for increasing redness, warmth, persistent swelling or a painful lump. Severe or unusual pain, pale, gray or blue skin near a filler injection, or any change in vision needs urgent medical attention. Breathing difficulty or tongue or throat swelling after dissolving also requires emergency care.
Safety information: FDA patient guidance on dermal fillers and signs of a serious reaction after dissolving.
The next step should feel clear by the end of your consultation. You should understand what is already present, which concern the proposed treatment addresses and when the result will be reviewed.
That plan may involve maintaining a result you already like, considering a conservative addition or addressing existing filler first. If dissolving is recommended, discuss how much change is intended and whether later refilling is part of your goal.
For an individual lip filler assessment in Dubai, book a consultation with Dr. Nivine Cheaito. Bring your previous treatment details and the questions that matter to you, so your next appointment can be planned around your lips, your history and your preferred result.
You do not automatically need Botox because you want to prevent wrinkles. If your skin is smooth both at rest and during expression, the benefit of starting injections purely for future prevention is not well established. If lines appear when you frown, smile or raise your eyebrows, there may be an existing concern to assess, even when your face looks smooth while relaxed.
That distinction matters. A useful first appointment should help you understand what your face is doing now, which changes concern you and whether treatment has a clear purpose. Your age or someone else’s treatment schedule cannot answer those questions for you.
Preventative Botox describes using botulinum toxin with the aim of reducing repeated muscle-related creasing before lines become more noticeable at rest. It is a way of describing a treatment goal, rather than a separate medicine or a standard plan everyone should follow.
Botox is a brand of onabotulinumtoxinA. It temporarily reduces the nerve signals that tell targeted muscles to contract. When those muscles move less strongly, the associated expression lines may soften.
The proposed preventive benefit comes from reducing that repeated folding over time. This does not mean the treatment stops facial aging. Sun exposure, changes in skin elasticity and changes in underlying facial tissues also affect how the face develops with age.
Clinical background: Botox Cosmetic prescribing information and Cleveland Clinic’s explanation of preventative treatment.
Dynamic lines appear with muscle movement. You might see them across the forehead when raising your eyebrows, between the brows when frowning or beside the eyes when smiling. They may become much less visible when your face relaxes.
Static lines remain visible when the face is at rest. A line can also have both components, staying faintly visible while relaxed and becoming deeper during expression.
This explains why someone can say they have no wrinkles while still noticing a strong crease in photographs taken mid-expression. The next question is whether that crease bothers them and whether reducing the muscle movement would create a worthwhile change.
Facial movement is normal. Its presence alone does not create a need for injections. Assessment should also distinguish expression lines from dryness, surface texture or folds related to facial structure.
Further reading: Cleveland Clinic’s explanation of dynamic and static wrinkles.
Botulinum toxin is established as a treatment for selected existing expression lines. The evidence for beginning before any lines appear is more limited. Reducing muscle-related creasing offers a plausible preventive effect, but it does not establish that every person with smooth skin benefits from starting now.
An often-cited study compared one pair of identical twins with different treatment histories over 13 years. The regularly treated twin had fewer persistent lines in the treated forehead and frown areas. This is a useful observation, but a single twin pair cannot establish a universal starting age or predict an individual’s long-term result.
A 2025 review also described possible preventive benefits while highlighting varied study methods and limited long-term evidence. Much of the research involves people with existing aesthetic concerns. It does not provide strong proof that routine injections in completely line-free adults are necessary.
The practical question remains whether the proposed treatment addresses something specific in your face today.
Clinical background: the identical-twin case report and a review of the preventive role of botulinum toxin.
A consultation may be useful when a particular expression line has started to bother you, even if it is not deeply visible at rest. You might notice a frown crease that has become more pronounced, forehead lines during conversation or crow’s feet you would like to soften while retaining your smile.
Your clinician should establish how much of that concern comes from muscle activity and what a realistic degree of improvement would look like. A faint crease that remains after expression also needs to be assessed in the context of skin condition and facial anatomy.
Early treatment should have a clear target. Explain the change you would like to see and the expressions you want to preserve. The decision can then be based on the likely benefit, your preferences and the treatment’s risks and maintenance.
If you have no visible lines and no specific change you want to make, observation is a reasonable option. The same applies when you are comfortable with your expressions or still deciding how you feel about treatment.
There is no single age when everyone should begin cosmetic Botox. Two adults of the same age may have different skin, muscle movement, sun exposure and priorities. A family tendency toward deeper lines can be part of the discussion, but it cannot determine your future treatment needs.
Waiting also gives you the chance to assess a concern over time. Photographs taken in similar lighting can help you describe changes at a later appointment. You do not need to schedule injections simply because friends have started or because a preventive package is available.
A useful starting point is how your face moves and what you would like to change.
A Botox assessment should include your face at rest and during movement. Your clinician may ask you to frown, smile and raise your eyebrows while considering line patterns, brow position, symmetry and the relationship between neighboring muscles.
Describe your goal in your own words. You may want to soften a particular frown line, retain visible forehead movement or understand whether an area needs treatment at all. These details are more useful than requesting the same treatment a friend received.
Share the information needed to plan safely, including:
Ask who will carry out the treatment, which product is proposed, what it is intended to change and how the result will be reviewed. The consultation should also make the cost clear before you decide.
Patient information: American Academy of Dermatology guidance on preparing for treatment.
A treatment plan can aim to soften selected lines while retaining movement. What feels natural to you should be discussed before the appointment, especially if you like an expressive forehead or the way your eyes move when you smile.
The result depends on the areas treated, the product, placement, amount and your individual anatomy. A smaller amount alone does not establish that a plan is appropriate. The balance between muscles and the intended degree of change also matter.
Ask what movement is expected to remain and what would count as too much change for your preference. This gives the review appointment a useful reference point. If you are uncertain, discuss a conservative plan and how the response would guide later decisions.
Patient information: AAD answers about treatment and facial expression.
Botox develops its effect over several days. Your clinician will advise when to review the response once it has had time to develop. Avoid judging the final balance immediately after the injections or arranging a first treatment just before an important event.
For facial lines, effects commonly last around three to four months, although the duration varies. Follow the aftercare advice provided and ask how to contact the practice if you have concerns.
One appointment does not commit you to ongoing treatment. If you choose not to repeat it, the muscle-relaxing effect wears off and movement gradually returns. Normal aging continues, so your face should not be expected to remain fixed at the appearance it had before you started.
If you do continue, the next appointment should reflect your response and current goals. It should not be based solely on a preset package or the assumption that more treatment will provide better prevention.
Patient information: Mayo Clinic’s guide to Botox treatment and duration and the temporary nature of its effects.
Possible effects include bruising, tenderness, swelling and headache. Unwanted changes in nearby muscle activity can cause temporary brow or eyelid drooping, asymmetry or changes in expression. Your clinician should explain the risks relevant to the area being considered.
Rare serious reactions can occur. Difficulty breathing, swallowing or speaking after an injection needs urgent medical attention. Previous reactions, infection at a proposed injection site and certain muscle or nerve conditions can affect suitability. Elective cosmetic Botox is generally deferred during pregnancy and breastfeeding.
When the hoped-for benefit is purely preventive, these considerations still apply. The term “preventative” does not make an injection free of risk.
Safety information: Botox Cosmetic prescribing information and Mayo Clinic’s patient guidance.
Consistent skin care has a useful role whether you choose injections or prefer to wait. Daily sun protection helps limit premature skin aging. Use a broad-spectrum, water-resistant sunscreen with SPF 30 or higher, together with shade, protective clothing and sunglasses.
Gentle cleansing and a suitable moisturizer can support skin comfort and reduce the appearance of dryness. If products repeatedly sting or irritate your skin, discuss the routine with your clinician. Avoid tanning, and seek support to stop smoking if relevant.
Sun protection and skin care remain useful because Botox does not address every cause of skin aging. They remain part of caring for your skin even when an expression-line treatment is appropriate. Your routine can be kept practical and adjusted to the condition of your skin.
Further reading: AAD guidance on reducing premature skin aging.
The most useful outcome of a first consultation is a clear decision. You should understand whether there is an expression line to treat, what improvement is realistic and whether the proposed approach suits your preferences.
That discussion may lead to treatment, a change in skin care or a decision to review later. If your face is smooth and you are happy with its movement, there may be no reason to begin injections now.
For an individual Botox consultation in Dubai, book an appointment with Dr. Nivine Cheaito. Bring your questions and any previous treatment details, so the next step can be planned around your facial expressions, your skin and the result you would feel comfortable with.
Weight loss can change how your face looks as well as how your clothes fit. You may be pleased with your progress while noticing less fullness in your cheeks, stronger shadows beneath your eyes or a different outline around your jaw. These changes are often described online as “Ozempic face.”
The phrase brings together several concerns that need different approaches. Understanding whether you are noticing reduced volume, looser skin or a change in texture makes the next step clearer. A facial assessment can help you explore those changes while keeping your health, your ongoing weight plan and your personal preferences in view.
Inside this article
“Ozempic face” is an informal expression for facial changes noticed during or after weight loss. Ozempic is a brand of semaglutide, a medicine in the GLP-1 group. The expression is not a formal diagnosis and does not describe a single appearance.
Similar changes can follow substantial weight loss through dietary changes, other weight management medicines or bariatric surgery. Research has not established whether GLP-1 medicines have a distinct effect on facial tissues beyond the effects associated with weight loss itself. The name alone therefore cannot explain what has changed in an individual’s face.
Clinical background: Cleveland Clinic’s explanation of the term and a systematic review of facial changes associated with GLP-1 treatment.
Fat beneath the skin contributes to facial fullness and the transitions between features. As that fullness reduces, the cheeks may look flatter and existing lines or folds can become more visible. Skin that previously covered a fuller contour may also appear looser.
The change is different for each person. The amount and pace of weight loss, age, existing facial anatomy and skin elasticity all matter. Some people welcome greater definition, while others feel that particular areas have become less balanced.
Changes you might notice include:
These observations are useful starting points for a consultation. A photograph alone cannot determine which tissues are responsible or which treatment would suit them.
Further reading: Cleveland Clinic on appearance changes during weight loss.
Reduced volume means there is less fullness beneath the skin. It may affect the contour of the cheeks or the transition between one area and the next. The assessment considers where that change has occurred and whether restoring some volume would support your preferred appearance.
Skin laxity describes skin that appears looser. It can coexist with reduced volume, but the amount of excess skin and the position of deeper tissues also influence the result. Adding fullness has limits when loose or descended tissue is the main concern.
Skin quality concerns the surface, including dryness, fine lines and uneven texture. These findings deserve their own assessment. Dry skin can make lines more noticeable even when the underlying facial contour has changed very little.
For example, someone who wants a softer cheek contour may have a different priority from someone bothered by neck laxity. Describing the change precisely helps keep the proposed treatment relevant.
You can seek an assessment while your weight is still changing. The consultation can clarify what you are noticing, discuss supportive care and establish whether treatment is appropriate now or better reviewed later.
Continued weight loss may change facial contours further, so more extensive correction may be easier to plan once it is clearer how much further your weight is likely to change. There is no single waiting interval that suits everyone. The decision should account for your medical plan, nutritional health, the concern being treated and the likelihood of further change.
It is also reasonable to give yourself time to become familiar with your appearance. Some concerns may feel different as you adjust, but a return to your previous facial fullness cannot be promised. You do not need to commit to a procedure at the first appointment.
Clinical background: current evidence and limitations in treatment planning after weight loss.
A useful assessment looks at the face as a whole, from the front and side and during expression. Your clinician should consider the distribution of fullness, skin condition, areas of laxity and any previous aesthetic treatment.
Bring earlier photographs if you have them. They can help you explain what feels different and which features you would like to preserve. Share details of:
You might want to soften one hollow area while retaining the definition you like elsewhere. That is a useful goal to discuss. The consultation should also explain the alternatives, expected recovery, costs and review plan before you decide.
A useful treatment plan starts with identifying which part of the face has changed.
Hyaluronic acid (HA) fillers can add volume to selected areas. They may be discussed when loss of fullness is contributing to a contour you would like to change. The choice of product, placement and amount depends on your anatomy and treatment goals.
A staged approach allows the result to be reviewed before more volume is considered. The aim may be to soften a particular transition while preserving the facial definition you enjoy. Under-eye shadows need a careful assessment of their cause before any injection is proposed.
Fillers carry risks, including swelling, bruising, infection and lumps. Rarely, injection into a blood vessel can cause serious tissue injury or vision loss. Your clinician should explain product-specific risks, aftercare and how to obtain help if a concern develops.
Patient information: FDA guidance on dermal fillers and their risks.
Collagen-stimulating injectables may enter the discussion when a gradual change in facial support or selected skin concerns is appropriate. Sculptra, for example, contains poly-L-lactic acid. Its intended effect develops over time through the tissue response, and its treatment course differs from an HA gel filler.
These products are not interchangeable. The proposed treatment should have a clear purpose, with realistic expectations about appointments, recovery and how the response will be assessed.
Research on these treatments specifically after weight loss with medication is still limited. One small, manufacturer-funded study of combined HA filler and poly-L-lactic acid reported improvements, but had no untreated comparison group. It does not establish a preferred combination for every patient.
Clinical background: published research on combined HA and poly-L-lactic acid treatment in GLP-1 medication users.
Skin boosters may be discussed when skin quality is a separate concern. Some injectable HA formulations have been studied for improvements in cheek smoothness and hydration. Those findings apply to the particular products, treatment areas and protocols studied.
This is a different goal from rebuilding a cheek contour. A treatment intended to improve skin texture does not recreate lost facial fat or remove excess skin. A consultation should identify the product being proposed and the specific improvement it is intended to achieve.
Dryness may also respond to a simpler skin care routine. An injection is not an automatic next step simply because the skin feels different during weight loss.
Clinical background: a randomized study of one HA formulation for skin quality.
When laxity is the main concern, an assessment may include discussion of skin-tightening treatments. Selected ultrasound or radiofrequency procedures can offer modest improvement for some people, depending on the device, the tissues being treated and the amount of laxity.
They have limitations. Significant excess skin may respond poorly to nonsurgical tightening, and adding more filler may not address the problem adequately. A suitably qualified specialist can discuss whether a surgical option deserves consideration when a larger correction is the goal.
Ask which tissue the proposed treatment targets, what change is realistic and which risks apply. This matters particularly when reduced facial fullness is already part of your concern.
Patient information: American Academy of Dermatology guidance on skin-tightening options and their limits.
A gentle cleanser, regular moisturizer and sun protection are practical foundations for skin care. Choose a broad-spectrum, water-resistant sunscreen with SPF 30 or higher, alongside shade and protective clothing. If your skin becomes dry or sensitive, ask whether irritating products need to be adjusted.
Nutrition also deserves attention if your appetite has fallen. Varied, nutrient-rich meals, adequate protein and fluids, and appropriate physical activity can support overall health. Resistance exercise can help preserve muscle during weight loss. Your prescribing clinician or a registered dietitian can tailor advice, especially if nausea or other symptoms make it difficult to eat enough.
These habits support your health and skin care. They cannot guarantee that facial hollowing will be prevented or that lost fullness will return. Persistent skin symptoms should be assessed individually.
Further reading: AAD skin care guidance during GLP-1 treatment and the joint nutrition advisory from four professional societies.
A personalized plan begins with the change that matters to you. You should leave the consultation understanding what is contributing to it, which options are suitable and when the result should be reviewed.
You may choose to address one area, take a gradual approach or continue observing as your weight settles. Aesthetic treatment is optional, and your preferred balance of fullness, definition and skin quality should guide the discussion.
For an individual facial assessment in Dubai, book a consultation with Dr. Nivine Cheaito. Bring your treatment history and the questions you would like to answer, so the next step can be planned around your face and your priorities.